Literature DB >> 2795596

Cytostatic trans-platinum(II) complexes.

N Farrell1, T T Ha, J P Souchard, F L Wimmer, S Cros, N P Johnson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2795596     DOI： 10.1021/jm00130a002

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  14 in total

1.  Synthesis, characterization and biological activity of trans-platinum(II) complexes with chloroquine.

Authors:  Maribel Navarro; William Castro; Angel R Higuera-Padilla; Anibal Sierraalta; María Jesús Abad; Peter Taylor; Roberto A Sánchez-Delgado
Journal:  J Inorg Biochem       Date:  2011-09-22       Impact factor: 4.155

Review 2.  Synthetic methods for the preparation of platinum anticancer complexes.

Authors:  Justin J Wilson; Stephen J Lippard
Journal:  Chem Rev       Date:  2013-11-27       Impact factor: 60.622

3.  Structural characterization and DNA interactions of new cytotoxic transplatin analogues containing one planar and one nonplanar heterocyclic amine ligand.

Authors:  Yousef Najajreh; Jana Kasparkova; Victoria Marini; Dan Gibson; Viktor Brabec
Journal:  J Biol Inorg Chem       Date:  2005-11-08       Impact factor: 3.358

4.  Steric control of DNA interstrand cross-link sites of trans platinum complexes: specificity can be dictated by planar nonleaving groups.

Authors:  V Brabec; K Neplechova; J Kasparkova; N Farrell
Journal:  J Biol Inorg Chem       Date:  2000-06       Impact factor: 3.358

Review 5.  The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.

Authors:  Timothy C Johnstone; Kogularamanan Suntharalingam; Stephen J Lippard
Journal:  Chem Rev       Date:  2016-02-11       Impact factor: 60.622

6.  Retained platinum uptake and indifference to p53 status make novel transplatinum agents active in platinum-resistant cells compared to cisplatin and oxaliplatin.

Authors:  Robert F Murphy; Edina Komlodi-Pasztor; Robert Robey; Frank M Balis; Nicholas P Farrell; Tito Fojo
Journal:  Cell Cycle       Date:  2012-03-01       Impact factor: 4.534

7.  Arene-Ru(II)-chloroquine complexes interact with DNA, induce apoptosis on human lymphoid cell lines and display low toxicity to normal mammalian cells.

Authors:  Alberto Martínez; Chandima S K Rajapakse; Roberto A Sánchez-Delgado; Armando Varela-Ramirez; Carolina Lema; Renato J Aguilera
Journal:  J Inorg Biochem       Date:  2010-05-15       Impact factor: 4.155

8.  cis-Tetrachlorido-bis(indazole)osmium(iv) and its osmium(iii) analogues: paving the way towards the cis-isomer of the ruthenium anticancer drugs KP1019 and/or NKP1339.

Authors:  Gabriel E Büchel; Susanne Kossatz; Ahmad Sadique; Peter Rapta; Michal Zalibera; Lukas Bucinsky; Stanislav Komorovsky; Joshua Telser; Jörg Eppinger; Thomas Reiner; Vladimir B Arion
Journal:  Dalton Trans       Date:  2017-09-12       Impact factor: 4.390

Review 9.  From cisplatin to artificial nucleases--the role of metal ion-nucleic acid interactions in biology.

Authors:  B Lippert
Journal:  Biometals       Date:  1992       Impact factor: 2.949

Review 10.  Unusual DNA binding modes for metal anticancer complexes.

Authors:  Ana M Pizarro; Peter J Sadler
Journal:  Biochimie       Date:  2009-04-01       Impact factor: 4.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.